Evidence map›Paper›PMID 32431289›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2020

Mortality impacts of the coronavirus disease (COVID-19) outbreak by sex and age: rapid mortality surveillance system, Italy, 1 February to 18 April 2020.

Paola Michelozzi, Francesca de'Donato, Matteo Scortichini, Manuela De Sario, Fiammetta Noccioli, Pasqualino Rossi, Marina Davoli

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Article
  2. Article
  3. Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  4. Observational
  5. Article
  6. Assessment of Excess Mortality in Italy in 2020-2021 as a Function of Selected Macro-Factors.International journal of environmental research and public health · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Quantifying and communicating the burden of COVID-19.BMC medical research methodology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paola MichelozziDepartment of Epidemiology, Lazio Regional Health Service, ASL Roma 1, Rome, Italy.
Francesca de'DonatoDepartment of Epidemiology, Lazio Regional Health Service, ASL Roma 1, Rome, Italy.
Matteo ScortichiniDepartment of Epidemiology, Lazio Regional Health Service, ASL Roma 1, Rome, Italy.
Manuela De SarioDepartment of Epidemiology, Lazio Regional Health Service, ASL Roma 1, Rome, Italy.
Fiammetta NoccioliDepartment of Epidemiology, Lazio Regional Health Service, ASL Roma 1, Rome, Italy.
Pasqualino RossiHealth Prevention Directorate, Italian Ministry of Health, Rome, Italy.
Marina DavoliDepartment of Epidemiology, Lazio Regional Health Service, ASL Roma 1, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Data from the rapid mortality surveillance system in 19 major Italian cities were used to carry out a timely assessment of the health impact of the COVID-19 epidemic. By 18 April, a + 45% excess in mortality was observed, with a higher impact in the north of the country (+ 76%). The excess was greatest among men, with an increasing trend by age. Surveillance data can be used to evaluate the lockdown and re-opening phases.

Indexed as

CoronavirusPandemicsPopulation SurveillanceAgedAged, 80 and overAge DistributionBetacoronavirusCoronavirus InfectionsCOVID-19Disease OutbreaksEpidemiological MonitoringFemaleHumansItalyMaleMiddle AgedCOVID-19demographic factorsmortalitysurveillance systemvulnerable populations

Identifiers

PMID32431289
PMCPMC7238743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.